What Previous Attendees Thought of the Summit?

Over the last 2 years, we have helped 250+ gene therapy drug developers from 80+ biopharma organizations to solve their immunogenicity challenges by:

  • Networking with KOL’s and industry leaders
  • Hearing world-class leading data from leading biopharma
  • Joining in-depth and intimate discussion sessions with their peers

Here’s what our previous attendees have said about their conference experience…

Adverum Logo

“The Gene Therapy Immunogenicity Summit is once again an extremely important venue for all new discoveries in Immunogenicity relating to Gene Therapy”

Head of Bioanalytical Assay Development, Adverum


“Very good conference. The quality of the speakers was great and so to was the audience. I am very much looking forward to the next meeting”

Chief Executive Officer & Founder, Chameleon Bioscience

Excision Bio Logo

“Speakers and the discussions were all excellent. The inclusion of the regulatory agency presentations was a stand-out. High quality science discussions and the Q&A session went fairly well. Will apply lessons imparted from this conference to my future sponsored clinical research.”

SVP, Excision Bio

Freeline Therapeutics Logo

“Good opportunity to learn about a new topic in gene therapy”

Principal Scientist Immunology, Freeline Therapeutics

Genethon Logo

“Great Q&A sessions and panel discussions”

Team Leader, Genethon

Precision Bio Logo

“I really appreciate that the organizer put together a strong program with a list of experts in the field, and covered several important areas of AAV immunogenicity that are critical for development of AAV based gene therapy products”

Associate Director, Precision Bio

Roche Logo

“Great presentations by academic and industry leaders, great discussions in the Q&A sessions and expert panels - fruitful discussions”

Principal Scientist, Roche

Tenaya Logo

“The focus on immunogenicity in gene therapy, covering mechanism, methods to prevent it, and assays to monitor it was very timely and helpful”

Director Translational Medicine, Tenaya